MEDULLARY CATECHOLAMINERGIC NEURONS IN THE NORMAL HUMAN BRAIN AND IN PARKINSONS-DISEASE

被引:75
|
作者
SAPER, CB
SORRENTINO, DM
GERMAN, DC
DELACALLE, S
机构
[1] UNIV CHICAGO, DEPT NEUROL, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, COMM NEUROBIOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, BRAIN RES INST, CHICAGO, IL 60637 USA
[4] UNIV TEXAS, SW MED CTR, DEPT PSYCHIAT, DALLAS, TX 75230 USA
[5] UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, DALLAS, TX 75230 USA
[6] UNIV NAVARRA, DEPT ANAT, PAMPLONA, SPAIN
关键词
D O I
10.1002/ana.410290602
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is thought to cause degeneration of melanin-pigmented catecholaminergic neurons throughout the brainstem, but little quantitative information is available on the fate of catecholaminergic neurons associated with the dorsal vagal complex or medullary reticular formation. We therefore examined these neurons in the normal human medulla and in the brains of patients with Parkinson's disease, using both a melanin stain and immunohistochemical methods with an antiserum against tyrosine hydroxylase. The greatest numbers of catecholaminergic neurons in the ventrolateral reticular formation (A1/C1 group) were located in the far rostral medulla, whereas the largest populations of catecholaminergic cells in the dorsal vagal complex (A2/C2 group) were found at the level of the area postrema. No loss of cells was observed in the A1/C1 group in the parkinsonian brains. In contrast, the A2/C2 group showed moderate loss of neurons, most marked at the level of the area postrema. This difference was entirely due to the loss of neurons in the medial component of the A2 group, a population that normally is only lightly pigmented, while the heavily pigmented neurons in the ventral and intermediate components of the A2 complex were unaffected. Parkinson's disease causes degeneration only of selected populations of medullary catecholaminergic neurons, without apparent relationship to the extent of melanin pigmentation.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 50 条
  • [1] CATECHOLAMINERGIC NEURONS IN THE PARABRACHIAL NUCLEUS OF NORMAL INDIVIDUALS AND PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE
    GOTO, S
    HIRANO, A
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 192 - 196
  • [2] BRAIN GABA NEURONS IN PARKINSONS-DISEASE
    LAAKSONEN, H
    RINNE, UK
    SONNINEN, V
    RIEKKINEN, P
    ACTA NEUROLOGICA SCANDINAVICA, 1978, 57 : 282 - 283
  • [3] DECREASE OF MEDULLARY CATECHOLAMINERGIC NEURONS IN MULTIPLE SYSTEM ATROPHY AND PARKINSONS-DISEASE AND THEIR PRESERVATION IN AMYOTROPHIC-LATERAL-SCLEROSIS
    KATO, S
    ODA, M
    HAYASHI, H
    SHIMIZU, T
    HAYASHI, M
    KAWATA, A
    TANABE, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 132 (02) : 216 - 221
  • [4] VARIATION DURING AGING IN THE NUMBER OF BRAIN-STEM CATECHOLAMINERGIC NEURONS SELECTIVELY VULNERABLE IN PARKINSONS-DISEASE
    KUBIS, N
    HIRSCH, EC
    FAUCHEUX, B
    RANSMAYR, G
    HAUW, JJ
    DUYCKAERTS, C
    HENIN, D
    MIKOL, J
    POLIVKA, M
    LECHARPENTIER, Y
    ROBAIN, O
    AGID, Y
    NEUROLOGY, 1995, 45 (04) : A239 - A240
  • [5] WHY ARE NIGRAL CATECHOLAMINERGIC NEURONS MORE VULNERABLE THAN OTHER CELLS IN PARKINSONS-DISEASE
    HIRSCH, EC
    ANNALS OF NEUROLOGY, 1992, 32 : S88 - S93
  • [6] ADRENAL-MEDULLARY TRANSPLANTATION FOR PARKINSONS-DISEASE
    CHOI, CR
    LEE, JS
    SUNG, KW
    SONG, JU
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1990, 54-5 : 324 - 327
  • [7] BRAIN BIOCHEMISTRY IN NORMAL AGING, SENILE DEMENTIA AND PARKINSONS-DISEASE
    NYBERG, P
    BUCHT, G
    NORDBERG, A
    WESTER, P
    WINBLAD, B
    ACTA NEUROLOGICA SCANDINAVICA, 1985, 71 (01): : 88 - 88
  • [8] BENZODIAZEPINE RECEPTORS IN NORMAL HUMAN-BRAIN, IN PARKINSONS-DISEASE AND IN PROGRESSIVE SUPRANUCLEAR PALSY
    MALOTEAUX, JM
    LUABEYA, MAK
    VANISBERG, MA
    LATERRE, EC
    LADURON, PM
    JAVOYAGID, F
    AGID, Y
    BRAIN RESEARCH, 1988, 446 (02) : 321 - 332
  • [9] ADRENAL-MEDULLARY TRANSPLANT TO THE BRAIN FOR PARKINSONS-DISEASE - NEUROPATHOLOGY OF AN UNSUCCESSFUL CASE
    FORNO, LS
    LANGSTON, JW
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1989, 48 (03): : 339 - 339
  • [10] HUMAN BRAIN PHENOLSULFOTRANSFERASE - REGIONAL DISTRIBUTION IN PARKINSONS-DISEASE
    BARAN, H
    JELLINGER, K
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (04) : 267 - 276